AAAAAA

   
Results: 1-19 |
Results: 19
SAFETY AND COST-EFFECTIVENESS OF A 10 X 10(9) L TRIGGER FOR PROPHYLACTIC PLATELET TRANSFUSIONS COMPARED WITH THE TRADITIONAL 20 X 10(9)/L TRIGGER - A PROSPECTIVE COMPARATIVE TRIAL IN 105 PATIENTS WITH ACUTE MYELOID-LEUKEMIA/
Authors: WANDT H FRANK M EHNINGER G SCHNEIDER C BRACK N DAOUD A FACKLERSCHWALBE I FISCHER J GACKLE R GEER T HARMS P LOFFLER B OHL S OTREMBA B RAAB M SCHONROCKNABULSI P STROBEL G WINTER R LINK H
Citation: H. Wandt et al., SAFETY AND COST-EFFECTIVENESS OF A 10 X 10(9) L TRIGGER FOR PROPHYLACTIC PLATELET TRANSFUSIONS COMPARED WITH THE TRADITIONAL 20 X 10(9)/L TRIGGER - A PROSPECTIVE COMPARATIVE TRIAL IN 105 PATIENTS WITH ACUTE MYELOID-LEUKEMIA/, Blood, 91(10), 1998, pp. 3601-3606
PHASE I II STUDY OF PACLITAXEL AND 5-FLUOROURACIL AS 2ND-LINE THERAPYIN PATIENTS WITH METASTATIC BREAST-CANCER/
Authors: GLEISSNER B HELLMANN A BERDEL WE EDLER L KOLDEHOFF M ROST A OPRI F FRITZE D OHL S
Citation: B. Gleissner et al., PHASE I II STUDY OF PACLITAXEL AND 5-FLUOROURACIL AS 2ND-LINE THERAPYIN PATIENTS WITH METASTATIC BREAST-CANCER/, Onkologie, 21(4), 1998, pp. 305-308
IMMUNOMAGNETIC ENRICHMENT OF DISSEMINATED EPITHELIAL TUMOR-CELLS FROMPERIPHERAL-BLOOD BY MACS
Authors: MARTIN VM SIEWERT C SCHARL A HARMS T HEINZE R OHL S RADBRUCH A MILTENYI S SCHMITZ J
Citation: Vm. Martin et al., IMMUNOMAGNETIC ENRICHMENT OF DISSEMINATED EPITHELIAL TUMOR-CELLS FROMPERIPHERAL-BLOOD BY MACS, Experimental hematology, 26(3), 1998, pp. 252-264
ASSIGNMENT OF THE HUMAN SERINE THREONINE PROTEIN PHOSPHATASE-4 GENE (PPP4C) TO CHROMOSOME 16P11-P12 BY FLUORESCENCE IN-SITU HYBRIDIZATION/
Authors: BASTIANS H KREBBER H HOHEISEL J OHL S LICHTER P PONSTINGL H JOOS S
Citation: H. Bastians et al., ASSIGNMENT OF THE HUMAN SERINE THREONINE PROTEIN PHOSPHATASE-4 GENE (PPP4C) TO CHROMOSOME 16P11-P12 BY FLUORESCENCE IN-SITU HYBRIDIZATION/, Genomics, 42(1), 1997, pp. 181-182
G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL
Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL, Experimental hematology, 25(8), 1997, pp. 35-35
ANALYSIS OF CHROMOSOMAL IMBALANCES IN VERY SMALL-CELL POPULATIONS BY UNIVERSAL PCR AND COMPARATIVE GENOMIC HYBRIDIZATION (CGH)
Authors: JOOS S OHL S LICHTER P
Citation: S. Joos et al., ANALYSIS OF CHROMOSOMAL IMBALANCES IN VERY SMALL-CELL POPULATIONS BY UNIVERSAL PCR AND COMPARATIVE GENOMIC HYBRIDIZATION (CGH), Cytogenetics and cell genetics, 77(1-2), 1997, pp. 5-5
EFFICACY OF CURRENT MOLECULAR CYTOGENETIC PROTOCOLS FOR THE DIAGNOSISOF CHROMOSOME-ABERRATIONS IN TUMOR SPECIMENS
Authors: LICHTER P FISCHER K JOOS S FINK T BAUDIS M POTKUL RK OHL S SOLINASTOLDO S WEBER R STILGENBAUER S BENTZ M DOHNER H
Citation: P. Lichter et al., EFFICACY OF CURRENT MOLECULAR CYTOGENETIC PROTOCOLS FOR THE DIAGNOSISOF CHROMOSOME-ABERRATIONS IN TUMOR SPECIMENS, Cytokines and molecular therapy, 2(3), 1996, pp. 163-169
INTENSIVE POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL
Authors: HUBNER G LINK H SCHONROCKNABULSI P WANDT H GRAMATZKI M LOFFLER B FACKLERSCHWALBE I QUEISSER W BRACK N GEER T RAAB M OHL S SCHNEIDER B SCHNEIDER C FREUND M POLIWODA H EHNINGER G
Citation: G. Hubner et al., INTENSIVE POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL, Medizinische Klinik, 91, 1996, pp. 26-32
EPIRUBICIN AND IFOSFAMIDE IN METASTATIC BREAST-CANCER
Authors: BECHER R KLOKE O HAYUNGS J HARTWICH G BARTELS H SZANTO J WOLF E ILLIGER HJ HALABI S RIECHE K HERING KG OHL S DEDYCKER R HUHN R FISCHEDICK AR HOFELER H PIELKEN HJ HAWIG I HIRCHE H SEEBER S
Citation: R. Becher et al., EPIRUBICIN AND IFOSFAMIDE IN METASTATIC BREAST-CANCER, Seminars in oncology, 23(3), 1996, pp. 28-33
LIVER-TRANSPLANTATION IN PRIMARY SCLEROSI NG CHOLANGITIS AND CHOLANGIOCARCINOMA - CASE-REPORT
Authors: KOLDEHOFF M HEINZE R OHL S
Citation: M. Koldehoff et al., LIVER-TRANSPLANTATION IN PRIMARY SCLEROSI NG CHOLANGITIS AND CHOLANGIOCARCINOMA - CASE-REPORT, Die medizinische Welt, 47(9), 1996, pp. 372-377
IN AML IMMUNOPHENOTYPING IS IMPORTANT FOR DIAGNOSIS AND PROGNOSIS
Authors: GRAMATZKI M REPP R DIEHL S STROBEL G WANDT H LOFFLER B BODENSTEIN H SCHONROCK P SCHLIMOK G HEIDEMANN E OTREMBA B OHL S SCHNEIDER C EHNINGER G LINK H
Citation: M. Gramatzki et al., IN AML IMMUNOPHENOTYPING IS IMPORTANT FOR DIAGNOSIS AND PROGNOSIS, Blood, 88(10), 1996, pp. 2230-2230
G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL
Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 2654-2654
ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH HIGH-DOSE ARA-C POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA
Authors: LINK H EHNINGER G",SCHONROCKNABULSI,GRAMATZKI,"FRANKE A EINSELE H TISCHLER J BRACK N OTREMBA B LUTZ M GACKLE R OHL S HEIDEMANN E WILHELM M LOFFLER B WEISS J GEER T DIEHL S WANDT H
Citation: H. Link et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH HIGH-DOSE ARA-C POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 2723-2723
HIGH-DOSE CYTOSINE-ARABINOSIDE AND DAUNORUBICIN POSTREMISSION THERAPYIN ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF A PROSPECTIVE MULTICENTER TRIAL
Authors: HEIL G MITROU PS HOELZER D FREUND M LINK H EHNINGER G STEINKE B OHL S WANDT H FACKLERSCHWALBE E SCHLIMOK G LOSCH A QUEISSER W LOFFLER B GAUS W HOGEL J HEIMPEL H KURRLE E
Citation: G. Heil et al., HIGH-DOSE CYTOSINE-ARABINOSIDE AND DAUNORUBICIN POSTREMISSION THERAPYIN ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF A PROSPECTIVE MULTICENTER TRIAL, Annals of hematology, 71(5), 1995, pp. 219-225
PHASE-II STUDY OF SUBCUTANEOUS ERYTHROPOIETIN FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES (FAB TYPE-I AND II) - A TRIAL OF THE PHASE-I PHASE-II STUDY-GROUP OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY
Authors: HARTUNG G WEIGOLD A OHL S ESSERS U HEIM ME FRITZE D BALDUS M HOELZER D BREMER K QUARDER O EDLER L QUEISSER W
Citation: G. Hartung et al., PHASE-II STUDY OF SUBCUTANEOUS ERYTHROPOIETIN FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES (FAB TYPE-I AND II) - A TRIAL OF THE PHASE-I PHASE-II STUDY-GROUP OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY, Onkologie, 18(5), 1995, pp. 451-455
HETEROGENEITY OF DELETIONS INVOLVING RB-1 AND THE D13S25 LOCUS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA REVEALED BY FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: STILGENBAUER S LEUPOLT E OHL S WEISS G SCHRODER M FISCHER K BENTZ M LICHTER P DOHNER H
Citation: S. Stilgenbauer et al., HETEROGENEITY OF DELETIONS INVOLVING RB-1 AND THE D13S25 LOCUS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA REVEALED BY FLUORESCENCE IN-SITU HYBRIDIZATION, Cancer research, 55(16), 1995, pp. 3475-3477
HETEROGENEITY OF DELETIONS INVOLVING RB-1 AND THE D13S25 LOCUS IN B-CLL REVEALED BY FISH
Authors: STILGENBAUER S LEUPOLT E OHL S WEISS G SCHRODER M FISCHER K BENTZ M LICHTER P DOHNER H
Citation: S. Stilgenbauer et al., HETEROGENEITY OF DELETIONS INVOLVING RB-1 AND THE D13S25 LOCUS IN B-CLL REVEALED BY FISH, Blood, 86(10), 1995, pp. 2960-2960
THE EFFECTS OF ANXIETY MANAGEMENT-TRAINING ON PSYCHOLOGICAL VARIABLESAND IMMUNE PARAMETERS IN CANCER-PATIENTS - A PILOT-STUDY
Authors: ELSESSER K VANBERKEL M SARTORY G BIERMANNGOCKE W OHL S
Citation: K. Elsesser et al., THE EFFECTS OF ANXIETY MANAGEMENT-TRAINING ON PSYCHOLOGICAL VARIABLESAND IMMUNE PARAMETERS IN CANCER-PATIENTS - A PILOT-STUDY, Behavioural and cognitive psychotherapy, 22(1), 1994, pp. 13-23
A NEW CLASS OF TOBACCO CHITINASES HOMOLOGOUS TO BACTERIAL EXO-CHITINASES IS ACTIVE AGAINST FUNGI IN-VITRO
Authors: OHL S APOTHEKERDEGROOT M VANDERKNAAP JA PONSTEIN AS SELABUURLAGE MB BOL JF CORNELISSEN BJC LINTHORST HJM MELCHERS LS
Citation: S. Ohl et al., A NEW CLASS OF TOBACCO CHITINASES HOMOLOGOUS TO BACTERIAL EXO-CHITINASES IS ACTIVE AGAINST FUNGI IN-VITRO, Journal of cellular biochemistry, 1994, pp. 90-90
Risultati: 1-19 |